02607 SH PHARMA
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.36X | Oper Margin | 3.4% |
|---|---|---|---|
| LT Debt/Equity | 13.6% | Net Margin | 1.7% |
| Total Debt/Equity | 66.7% | Return on Equity | 6.4% |
| Price/Book | 0.58X | Return on Assets | 2.1% |
| (HKD 11.850) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 4,841.61 | 4,153.09 | 6,297.95 | 6,229.82 | 5,336.11 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +16.6 | -34.1 | +1.1 | +16.8 | +17.0 |
| Earnings Per Share (HKD) | 1.307 | 1.122 | 1.808 | 2.192 | 1.878 |
| Earnings Per Share Growth (%) | +16.5 | -38.0 | -17.5 | +16.8 | +17.0 |
| Dividend Per Share (HKD) | 0.404 | 0.441 | 0.664 | 0.492 | 0.576 |
| P/E* (X) | 9.07 | 10.56 | 6.55 | 5.41 | 6.31 |
| Yield (%) | 3.41 | 3.72 | 5.60 | 4.15 | 4.86 |
| Dividend Share (%) | 30.93 | 39.27 | 36.71 | 22.45 | 30.69 |
| Book NAV (HKD) | 20.558 | 20.395 | 20.335 | 21.242 | 18.939 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-12-15 21:40:20
Latest Result
| (RMBMn) | 2025-09 | 2024-09 | Chg* (%) | 2023-09 |
| Cover Period (mths) | 9 | 9 | NA | 9 |
|---|---|---|---|---|
| Turnover | 215,072 | 209,629 | +2.6 | 197,508 |
| Operating Result | 7,697 | 6,075 | +26.7 | 6,361 |
| Associates | 479.617 | 447.826 | +7.1 | 89.919 |
| Profit Before Taxation | 8,298 | 6,644 | +24.9 | 6,519 |
| Taxation | 2,312 | 1,621 | +42.6 | 1,565 |
| Profit /( Loss) After Taxation | 5,986 | 5,023 | +19.2 | 4,954 |
| Minority Interests | 839.085 | 969.12 | -13.4 | 1,157 |
| Net Profit | 5,147 | 4,054 | +27.0 | 3,797 |
| Earnings Per Share () | 1.5186 | 1.2071 | +25.8 | 1.1047 |
| Announcement Date | 2025-10-30 | 2024-10-29 | NA | 2023-10-27 |
* Annualised
Last Update Time: 2025-12-15 21:40:25
